Acute chest pain (ACP) is a common yet challenging presentation in emergency departments. Its etiology ranges from benign conditions to life-threatening diseases, making a prompt and precise diagnosis crucial. This article elucidates a comprehensive approach to diagnosing and managing ACP.
Firstly, a thorough history and physical examination are essential. The nature, onset, location, and radiation of the pain, associated symptoms, and risk factors for cardiovascular disease should be elicited. Physical examination should focus on vital signs, heart and lung examination, and signs of peripheral vascular disease.
Electrocardiogram and cardiac biomarkers are the first-line diagnostic tests. They should be performed immediately upon suspicion of ACP. Other investigations like chest radiography, computed tomography, and echocardiography should be considered based on clinical suspicion.
Risk stratification is crucial to guide management. Various validated clinical decision rules such as the HEART score, TIMI risk score, etc., can be utilized. These tools combine clinical variables and diagnostic test results to predict the likelihood of major adverse cardiac events.
Management depends on the underlying cause. In cases of acute coronary syndrome, immediate revascularization is often required. Non-cardiac causes should be managed accordingly. Regardless of the cause, all patients should receive symptomatic treatment, risk factor modification, and appropriate follow-up.
ACP is a complex clinical entity requiring a systematic approach for optimal patient outcomes. A thorough history, physical examination, appropriate diagnostic testing, and risk stratification form the cornerstone of its management. As physicians, we must remain vigilant and adaptable in our approach to this common yet challenging clinical presentation.
1.
Race, Geography Linked to Gaps in Prostate Cancer Care
2.
Sports for girls are frequently abandoned due to uniform issues.
3.
According to the Lancet, having cancer and VTE at the same time increases mortality risk.
4.
Temsirolimus Plus Chemotherapy Fails in Rare Childhood Cancer
5.
Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma
1.
Hematopoietic Clonal Competition in Blood Disorders
2.
Managing KRAS Inhibitor Toxicities: Focus on Rash and Beyond
3.
Developmental Iron Biology Beyond Infancy: Mechanisms, Clinical Implications, and Emerging Directions
4.
Next-Generation Bone Marrow Harvest Technologies
5.
Strategic Applications in Hematology in Clinical Decision-Making
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Understanding the Common Causes of Anemia
2.
The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion
3.
Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma
4.
Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part IV
5.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation